Literature DB >> 22949772

Exclusion of the left atrial appendage to prevent stroke in cases of atrial fibrillation.

Armin Barekatain1, Abdi Rasekh, Ali Massumi.   

Abstract

Entities:  

Keywords:  Anticoagulants; atrial appendage/surgery; atrial fibrillation/therapy; fibrinolytic agents; stroke/prevention & control; throm-boembolism/prevention & control; warfarin

Mesh：

Year:  2012        PMID： 22949772      PMCID： PMC3423289     

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


× No keyword cloud information.
  14 in total

Review 1.  Atrial fibrillation: the most common arrhythmia.

Authors:  C R Wyndham
Journal:  Tex Heart Inst J       Date:  2000

2.  Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  John J You; Daniel E Singer; Patricia A Howard; Deirdre A Lane; Mark H Eckman; Margaret C Fang; Elaine M Hylek; Sam Schulman; Alan S Go; Michael Hughes; Frederick A Spencer; Warren J Manning; Jonathan L Halperin; Gregory Y H Lip
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli.

Authors:  J L MADDEN
Journal:  J Am Med Assoc       Date:  1949-07-02

4.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey.

Authors:  Ron Pisters; Deirdre A Lane; Robby Nieuwlaat; Cees B de Vos; Harry J G M Crijns; Gregory Y H Lip
Journal:  Chest       Date:  2010-03-18       Impact factor: 9.410

5.  Is CHA2DS2-VASc score a predictor of left atrial thrombus in patients with paroxysmal atrial fibrillation?

Authors:  R-B Tang; J-Z Dong; X-P Liu; D-Y Long; R-H Yu; X Du; X-H Liu; C-S Ma
Journal:  Thromb Haemost       Date:  2011-05-05       Impact factor: 5.249

6.  2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 Guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines developed in partnership with the European Society of Cardiology and in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society.

Authors:  Valentin Fuster; Lars E Rydén; Davis S Cannom; Harry J Crijns; Anne B Curtis; Kenneth A Ellenbogen; Jonathan L Halperin; G Neal Kay; Jean-Yves Le Huezey; James E Lowe; S Bertil Olsson; Eric N Prystowsky; Juan Luis Tamargo; L Samuel Wann
Journal:  J Am Coll Cardiol       Date:  2011-03-15       Impact factor: 24.094

7.  Feasibility of closed-chest ligation of the left atrial appendage in humans.

Authors:  Krzysztof Bartus; Jacek Bednarek; Jacek Myc; Boguslaw Kapelak; Jerzy Sadowski; Jacek Lelakowski; Steven J Yakubov; Randall J Lee
Journal:  Heart Rhythm       Date:  2010-11-02       Impact factor: 6.343

8.  Warfarin use among ambulatory patients with nonvalvular atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.

Authors:  A S Go; E M Hylek; L H Borowsky; K A Phillips; J V Selby; D E Singer
Journal:  Ann Intern Med       Date:  1999-12-21       Impact factor: 25.391

9.  The PROTECT AF (WATCHMAN Left Atrial Appendage System for Embolic PROTECTion in Patients with Atrial Fibrillation) trial.

Authors:  Rebecca Brown Fountain; David R Holmes; Krishnaswamy Chandrasekaran; Douglas Packer; Samuel Asirvatham; Robert Van Tassel; Zoltan Turi
Journal:  Am Heart J       Date:  2006-05       Impact factor: 4.749

10.  Meta-analysis: antithrombotic therapy to prevent stroke in patients who have nonvalvular atrial fibrillation.

Authors:  Robert G Hart; Lesly A Pearce; Maria I Aguilar
Journal:  Ann Intern Med       Date:  2007-06-19       Impact factor: 25.391
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.